These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 2139075
1. Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro. Maliszewski CR, Sato TA, Vanden Bos T, Waugh S, Dower SK, Slack J, Beckmann MP, Grabstein KH. J Immunol; 1990 Apr 15; 144(8):3028-33. PubMed ID: 2139075 [Abstract] [Full Text] [Related]
2. Induction of B cell activities by interleukin 4 is inhibited by a receptor-specific monoclonal antibody in vitro. Maliszewski CR, Sato TA, Vanden Bos T, Beckmann MP, Grabstein KH. Eur J Immunol; 1990 Aug 15; 20(8):1735-40. PubMed ID: 2145164 [Abstract] [Full Text] [Related]
3. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. Fanslow WC, Clifford KN, Park LS, Rubin AS, Voice RF, Beckmann MP, Widmer MB. J Immunol; 1991 Jul 15; 147(2):535-40. PubMed ID: 1830065 [Abstract] [Full Text] [Related]
4. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. Sato TA, Widmer MB, Finkelman FD, Madani H, Jacobs CA, Grabstein KH, Maliszewski CR. J Immunol; 1993 Apr 01; 150(7):2717-23. PubMed ID: 8454851 [Abstract] [Full Text] [Related]
5. Production of soluble IL-4 receptors by murine spleen cells is regulated by T cell activation and IL-4. Chilton PM, Fernandez-Botran R. J Immunol; 1993 Dec 01; 151(11):5907-17. PubMed ID: 8245438 [Abstract] [Full Text] [Related]
6. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4. Schnare M, Blum H, Jüttner S, Röllinghoff M, Gessner A. J Immunol; 1998 Oct 01; 161(7):3484-92. PubMed ID: 9759868 [Abstract] [Full Text] [Related]
7. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor. Galizzi JP, Cabrillat H, Rousset F, Ménétrier C, de Vries JE, Banchereau J. J Immunol; 1988 Sep 15; 141(6):1982-8. PubMed ID: 2844892 [Abstract] [Full Text] [Related]
8. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity. Uchibayashi N, Kikutani H, Barsumian EL, Hauptmann R, Schneider FJ, Schwendenwein R, Sommergruber W, Spevak W, Maurer-Fogy I, Suemura M. J Immunol; 1989 Jun 01; 142(11):3901-8. PubMed ID: 2523938 [Abstract] [Full Text] [Related]
9. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. Garrone P, Djossou O, Galizzi JP, Banchereau J. Eur J Immunol; 1991 Jun 01; 21(6):1365-9. PubMed ID: 1828424 [Abstract] [Full Text] [Related]
10. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor. Blum H, Wolf M, Enssle K, Röllinghoff M, Gessner A. J Immunol; 1996 Sep 01; 157(5):1846-53. PubMed ID: 8757301 [Abstract] [Full Text] [Related]
11. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D). König B, Fischer A, König W. Immunology; 1995 Aug 01; 85(4):604-10. PubMed ID: 7558156 [Abstract] [Full Text] [Related]
12. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used. Callard RE, Rigley KP, Smith SH, Thurstan S, Shields JG. J Immunol; 1992 May 15; 148(10):2983-7. PubMed ID: 1374445 [Abstract] [Full Text] [Related]
13. B cell activator. Effects on B cell expression of CD23, proliferation, and antibody secretion. Marcelletti JF, Matsushita S, Katz DH. J Immunol; 1992 Jun 15; 148(12):3857-63. PubMed ID: 1318334 [Abstract] [Full Text] [Related]
14. Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4. Dugas B, Paul-Eugene N, Cairns J, Gordon J, Calenda A, Mencia-Huerta JM, Braquet P. J Immunol; 1990 Nov 15; 145(10):3406-11. PubMed ID: 2172383 [Abstract] [Full Text] [Related]
15. Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation. Zuber CE, Galizzi JP, Vallé A, Harada N, Howard M, Banchereau J. Eur J Immunol; 1990 Mar 15; 20(3):551-5. PubMed ID: 2318249 [Abstract] [Full Text] [Related]
16. Expression of B cell surface receptors. II. IL-4 can accelerate the developmental expression of the murine B cell IgE Fc receptor. Waldschmidt TJ, Conrad DH, Lynch RG. J Immunol; 1989 Nov 01; 143(9):2820-7. PubMed ID: 2530279 [Abstract] [Full Text] [Related]
17. Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases. Nasert S, Millner M, Herz U, Lack G, Wahn U, Gelfand EW, Renz H. Behring Inst Mitt; 1995 Jun 01; (96):118-30. PubMed ID: 7575347 [Abstract] [Full Text] [Related]
18. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. Finkelman FD, Madden KB, Morris SC, Holmes JM, Boiani N, Katona IM, Maliszewski CR. J Immunol; 1993 Aug 01; 151(3):1235-44. PubMed ID: 8393043 [Abstract] [Full Text] [Related]
19. Linked in vivo expression of soluble interleukin-4 receptor and interleukin-4 in murine schistosomiasis. Fernandez-Botran R, Wynn TA, Hieny S, Caspar P, Chilton PM, Sher A. Eur J Immunol; 1995 Mar 01; 25(3):649-56. PubMed ID: 7705393 [Abstract] [Full Text] [Related]
20. The production of soluble interleukin 4 receptors is preferentially regulated by the murine Th2 cell subset. Fernandez-Botran R, Chilton PM, Ma Y, Windsor JL, Street NE. Cytokine; 1997 Mar 01; 9(3):166-77. PubMed ID: 9126705 [Abstract] [Full Text] [Related] Page: [Next] [New Search]